stiffness of the shoulders
Conditions
Interventions
Korispot
placebo
Sponsors
Kanazawa University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Complain of stiffness of shoulders Patients whose Visual Analogue Scale (VAS) value before treatment is 50% or more
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The VAS value of before treatment and 1 hour, 1 day, 2 days, 3 days after the treatment are exploratively evaluated with Korispot or placebo. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events 3 days after the start of application are evaluated using Adverse Event Common Term Criteria v 4.0 with Korispot or placebo. | — |
Countries
Japan
Contacts
Public ContactKeiko Ogawa
Kanazawa University Hospital Department of Japanese-Traditional (Kampo) Medicine
Outcome results
None listed